Botulinum Toxin for Treating Low Back Pai
Phase 3
Completed
- Conditions
- Health Condition 1: M519- Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder
- Registration Number
- CTRI/2022/08/044530
- Lead Sponsor
- AIIMS Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
1. Patients with chronic low back pain > 3 months
2. Without red flags (history suggestive of tumor, trauma, infection, malignancy or cauda equina syndrome),
3.Aged between 18-60 years
4. Willing to participate
•Will be investigated with calcium, Vit D and X rays
Exclusion Criteria
•Acute low back pain,
•Known systemic disorders,
•Spinal deformities
•Neuromuscular weakness
•Malignancy
•Bleeding disorders
•History of back surgeries
•Known allergies to the BoNT-A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method